Patents
Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
10/2007
10/18/2007US20070244049 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
10/18/2007US20070243629 High Affinity Ligands for Influenza Virus and Methods for Their Production
10/18/2007US20070243209 Compositions and methods for prevention and treatment of fungal diseases
10/18/2007CA2648403A1 Soluble virus-specific t-cell receptor compositions
10/10/2007EP1841784A1 Vacuole targeting peptide and nucleic acid
10/04/2007WO2007051477A3 Neurotrophin-derived peptide sequences
10/04/2007WO2005030133A3 Treatment with agonists of toll-like receptors
10/04/2007WO2004071457A3 Improved heat shock protein-based vaccines and immunotherapies
10/04/2007US20070232537 Intranasal pyy formulations with improved transmucosal pharmacokinetics
10/02/2007US7276595 DNA sequence encoding a retinoic acid regulated protein
10/02/2007US7276581 Tyrosine kinases; phosphoproteins; antibodies; transgenic mice whose somatic or germ cells express tumors
09/2007
09/27/2007US20070225209 Compositions and methods for treating neurological disorders and diseases
09/27/2007CA2680413A1 Use of gelsolin to diagnose and treat inflammatory diseases
09/26/2007CN100339388C New assays for preimplantation factor and preimplantation factor peptides
09/25/2007US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses
09/20/2007WO2007039728A3 AVß6 PEPTIDE LIGANDS AND THEIR USES
09/20/2007US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens
09/20/2007US20070218080 Peptide antigen of human papillomavirus type 16 and application thereof
09/19/2007CN101039953A Therapeutic and diagnostic agents
09/18/2007US7271240 Protein for use as diagnostic and therapeutic tool in cancer treatment
09/18/2007US7270980 Diagnosing prostate cancer in humans; obtain sample, incubate with preferential binding agent, detect bound protein, bound protein indicates prostate cancer
09/13/2007US20070213507 Methods and reagents for decreasing clinical reaction to allergy
09/11/2007US7268208 Solubility in aqueous solvents; for use in diagnosis, therapy
09/11/2007US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer
09/07/2007WO2006020541A3 Methods for synthesizing polypeptides
09/06/2007US20070207506 G-protein coupled receptor and DNA sequences thereof
09/05/2007CN101029079A Production of sulfating fibroin protein and its use in anticoagulant
09/04/2007US7264808 Synthetic peptide for neurological disorders
08/2007
08/30/2007US20070203325 Integrase-dirived HIV-inhibiting agents
08/30/2007US20070203070 28 human secreted proteins
08/30/2007US20070202575 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent
08/28/2007US7262163 The peptides exhibit in vitro anti-bacterial properties at concentrations that are not lethal to normal mammalian cells
08/21/2007US7259004 Endophytic streptomycetes from higher plants with biological activity
08/16/2007WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
08/16/2007US20070190633 Endophytic streptomycetes from higher plants with biological activity
08/14/2007US7256252 Methods for detecting cell apoptosis
08/09/2007WO2004099432A3 Identification of biomarkers for detecting pancreatic cancer
08/08/2007EP1474423B1 Heterocyclic tripeptides as hepatitis c inhibitors
08/07/2007US7252829 HLA binding peptides and their uses
08/02/2007WO2007086637A1 Mass producing method of growth factor using adipose derived adult stem cells
08/02/2007US20070179278 HIV fusion inhibitor peptides with improved biological properties
08/01/2007EP1594442A4 Knockout identification of target-specific sites in peptides
07/2007
07/25/2007EP1073475B1 Improvements in or relating to diagnostic/therapeutic agents
07/24/2007US7247703 Anticancer agents; protein complex
07/19/2007US20070166346 Method for coating an object with hydrophobin at low temperatures
07/12/2007WO2007076776A1 Method and device for vacuum drying papaya latex
07/12/2007WO2006123926A3 Peptide composition for growing and/or culturing micro-organisms and/or cells
07/11/2007EP1730278A4 Method for preparation and purification of recombinant proteins
07/10/2007US7241866 Using amines or amino acids as mobile phase modifiers in chromatography
07/10/2007US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
07/10/2007US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to
07/04/2007CN1993141A Induction of an immune response against streptococcus pneumoniae polysaccharides
07/04/2007CN1323989C Improved extraction process
06/2007
06/28/2007WO2007072976A1 A method of producing a multimeric capture agent for binding a ligand
06/28/2007WO2007072975A1 Method for functionalising a hydrophobic substrate
06/28/2007WO2007072973A1 Novel capture agents for binding a ligand
06/28/2007US20070149761 To evaluate the effectiveness of a compound to inhibit NS5B activity
06/14/2007US20070134729 Novel antibacterial agents
06/13/2007EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor
06/12/2007CA2057828C Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
06/06/2007EP1792911A1 Amino acid sequence essential to neurospecific gene expression
06/06/2007EP1791969A2 A method of treating cancer
06/06/2007EP1791857A1 Conformational switches in toxin folding and uses thereof
06/05/2007US7226992 proteins of the present invention can be used in biological assays to identify substances which block the ability of Bcl-2 to inhibit programmed cell death
05/2007
05/31/2007US20070123696 G-csf conjugates
05/30/2007CN1973053A Novel anti-IL 13 antibodies and uses thereof
05/29/2007US7223837 Anticancer prodrugs, enhance enzymatic activation rates
05/29/2007US7223564 Four-helical bundle protein zsig81
05/22/2007US7220823 A 710 amino acid protein containing 13 transmembrane domains and bearing homology to murine and C. elegans genes containing 12 transmembrane domains
05/22/2007US7220405 Peptide-based conditioners and colorants for hair, skin, and nails
05/22/2007CA2205420C Substance mk7634, process for production thereof, and anthelminthic containing said substance
05/18/2007WO2003077872A3 Cell surface tropomyosin as a target of angiogenesis inhibition
05/18/2007CA2629113A1 Metal-binding therapeutic peptides
05/16/2007EP1415006B1 Assay for identifying inhibitors of hiv rt dimerization
05/10/2007US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines
05/10/2007DE102005053011A1 Use of tetraorganosilicon compound having cell proliferation inhibitory activity, e.g. as an immunstimulator to treat viral-, bacterial- and/or tumor diseases, anemia, arteriosclerosis, arthritis, asthma, autoimmune disease, and cirrhosis
05/10/2007CA2628843A1 Neurotrophin-derived peptide sequences
05/09/2007EP1783139A2 Human telomerase catalytic subunit
05/09/2007EP1781685A1 Therapeutic and diagnostic agents
05/09/2007EP1781326A2 Induction of an immune response against streptococcus pneumoniae polysaccharides
05/08/2007CA2137912C Combinatorial polypeptide antigens
05/03/2007WO2007015841A3 A method for treating preeclampsia
04/2007
04/26/2007WO2007046729A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
04/25/2007CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
04/19/2007WO2004058189A3 Chemokine antagonists and uses thereof
04/18/2007EP1606232A4 Improved extraction process
04/12/2007CA2624618A1 Av.beta.6 peptide ligands and their uses
04/11/2007CN1946736A REPLIKIN peptides and uses thereof
04/10/2007US7201904 Epitopes of hepatitis C virus
04/10/2007CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
03/2007
03/29/2007WO2006110881A3 Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins
03/29/2007US20070073039 Peptides that inhibit viral infections
03/22/2007US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor
03/22/2007US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents
03/20/2007US7192928 T cell antigen receptor peptides
03/15/2007WO2006116737A3 Compounds and methods for modulating cadherin-mediated processes
03/13/2007US7189800 Forming vaccines; analyzing hemagglutinin, calibration
03/13/2007US7189523 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
03/07/2007EP1646646B1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof.
02/2007
02/22/2007WO2007021253A1 Compounds and methods for inhibiting hepatitis c virus replication
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 22